NYSE American - Delayed Quote USD

Stereotaxis, Inc. (STXS)

Compare
1.8900 -0.0200 (-1.05%)
At close: October 25 at 4:00 PM EDT
1.8900 0.00 (0.00%)
After hours: October 25 at 4:07 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A. CEO & Chairman 62.2k -- 1987
Ms. Kimberly R. Peery CFO & Secretary 251.76k -- 1969
Mr. Keith Galloway Vice President of Operations -- -- --

Stereotaxis, Inc.

710 North Tucker Boulevard
Suite 110
Saint Louis, MO 63101
United States
314 678 6100 https://www.stereotaxis.com
Sector:?
Healthcare
Full Time Employees:?
122

Description

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

Corporate Governance

Stereotaxis, Inc.’s ISS Governance QualityScore as of October 1, 2024 is 10. The pillar scores are Audit: 9; Board: 8; Shareholder Rights: 10; Compensation: 7.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 11, 2024 at 9:00 PM UTC

Stereotaxis, Inc. Earnings Date

Recent Events

September 9, 2024 at 12:00 AM UTC

CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission

September 6, 2024 at 12:00 AM UTC

S-8 POS: Offering Registrations

August 23, 2024 at 12:00 AM UTC

S-3: Offering Registrations

August 15, 2024 at 12:00 AM UTC

D: Additional Forms

August 14, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

August 12, 2024 at 8:30 PM UTC

Q2 2024 Earnings Call

August 12, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

August 2, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 18, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

May 30, 2024 at 12:00 AM UTC

SD: Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)

Related Tickers